SE0001187D0 - Crystalline form - Google Patents

Crystalline form

Info

Publication number
SE0001187D0
SE0001187D0 SE0001187A SE0001187A SE0001187D0 SE 0001187 D0 SE0001187 D0 SE 0001187D0 SE 0001187 A SE0001187 A SE 0001187A SE 0001187 A SE0001187 A SE 0001187A SE 0001187 D0 SE0001187 D0 SE 0001187D0
Authority
SE
Sweden
Prior art keywords
crystalline form
crystalline
Prior art date
Application number
SE0001187A
Other languages
Swedish (sv)
Inventor
Maria Boije
Tord Inghardt
Karol Horwath
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0001187A priority Critical patent/SE0001187D0/en
Publication of SE0001187D0 publication Critical patent/SE0001187D0/en
Priority to CZ20021902A priority patent/CZ20021902A3/en
Priority to AU20350/01A priority patent/AU773777B2/en
Priority to SI200030350T priority patent/SI1237855T1/en
Priority to PT00983618T priority patent/PT1237855E/en
Priority to CNB008163804A priority patent/CN1198799C/en
Priority to MXPA02005327A priority patent/MXPA02005327A/en
Priority to BR0016131-4A priority patent/BR0016131A/en
Priority to NZ518925A priority patent/NZ518925A/en
Priority to IL14957700A priority patent/IL149577A0/en
Priority to PCT/SE2000/002384 priority patent/WO2001040171A1/en
Priority to RU2002113450/04A priority patent/RU2268880C2/en
Priority to HU0203444A priority patent/HUP0203444A3/en
Priority to JP2001541858A priority patent/JP2003515582A/en
Priority to KR1020027007071A priority patent/KR20030029040A/en
Priority to SK765-2002A priority patent/SK7652002A3/en
Priority to EEP200200278A priority patent/EE200200278A/en
Priority to DE60008921T priority patent/DE60008921T2/en
Priority to DK00983618T priority patent/DK1237855T3/en
Priority to TR2004/01333T priority patent/TR200401333T4/en
Priority to US10/148,821 priority patent/US6531622B1/en
Priority to ES00983618T priority patent/ES2215769T3/en
Priority to EP00983618A priority patent/EP1237855B1/en
Priority to CA002392038A priority patent/CA2392038A1/en
Priority to AT00983618T priority patent/ATE261431T1/en
Priority to PL00357118A priority patent/PL357118A1/en
Priority to CO00091767A priority patent/CO5271735A1/en
Priority to MYPI20005604A priority patent/MY135954A/en
Priority to ARP000106382A priority patent/AR029412A1/en
Priority to IS6400A priority patent/IS6400A/en
Priority to NO20022598A priority patent/NO20022598D0/en
Priority to HK03101132A priority patent/HK1048980A1/en

Links

SE0001187A 1999-12-03 2000-04-03 Crystalline form SE0001187D0 (en)

Priority Applications (32)

Application Number Priority Date Filing Date Title
SE0001187A SE0001187D0 (en) 2000-04-03 2000-04-03 Crystalline form
AU20350/01A AU773777B2 (en) 1999-12-03 2000-11-29 Crystalline form of (S)-2 ethoxy-3-(4-(2-(4-methanesulfonyloxyphenyl) ethoxy) phenyl) propanoic acid
KR1020027007071A KR20030029040A (en) 1999-12-03 2000-11-29 Crystalline Form of (S)―2―ethoxy―3―〔4―(2―{4―methanesulfonyloxyphenyl}ethoxy)phenyl〕 propanoic acid
DE60008921T DE60008921T2 (en) 1999-12-03 2000-11-29 CRYSTALLINE FORM OF (S) -2-ETHOXY-3-4- (2-4-METHANSULFONYLOXYPHENYL-ETHOXY) PHENYL] PROPANIC ACID
SK765-2002A SK7652002A3 (en) 1999-12-03 2000-11-29 Crystalline form of (s)-2-ethoxy-3-[4-(2-{4- methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid
PT00983618T PT1237855E (en) 1999-12-03 2000-11-29 (S) -2-ETOXY-3 - [4- (2- {4-METHOSULPHONYL-OXYPHENYL} ETHOXY) PHENYL] PROPANOIC CRYSTALLINE FORM
CNB008163804A CN1198799C (en) 1999-12-03 2000-11-29 Crystalline form of (S)-2-ethoxy-3-[4-(2-{4-methane sulfonyloxy phenyl} ethoxy) phenyl] propanoic acid
MXPA02005327A MXPA02005327A (en) 1999-12-03 2000-11-29 CRYSTALLINE FORM OF (S) 2 ETHOXY 3 [4 (2 lcub;4 METHANESULFONYLOXYPHENYLrcub; ETHOXY) PHENYL] PROPANOIC ACID.
BR0016131-4A BR0016131A (en) 1999-12-03 2000-11-29 Crystalline form, pharmaceutical formulation, use of a crystalline form, use of a substance, methods for the treatment or prophylaxis of, conditions associated with reduced insulin sensitivity, and delipidemia, type 2 diabetes mellitus, hyperglycemia, hyperinsulinemia, hypertension and / or abdominal obesity, and, process for the preparation of a crystalline form of a compound of formula i
NZ518925A NZ518925A (en) 1999-12-03 2000-11-29 Crystalline form of (S)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid
IL14957700A IL149577A0 (en) 1999-12-03 2000-11-29 Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl] propanoic acid
PCT/SE2000/002384 WO2001040171A1 (en) 1999-12-03 2000-11-29 Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid
RU2002113450/04A RU2268880C2 (en) 1999-12-03 2000-11-29 Crystalline form of (s)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl]propanoic acid
HU0203444A HUP0203444A3 (en) 1999-12-03 2000-11-29 Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl]propanoic acid, process for its preparation, pharmaceutical composition containing it and use thereof
JP2001541858A JP2003515582A (en) 1999-12-03 2000-11-29 Crystal form of (S) -2-ethoxy-3- [4- (2- {4-methanesulfonyloxyphenyl} ethoxy) phenyl] propionic acid
CZ20021902A CZ20021902A3 (en) 1999-12-03 2000-11-29 Crystalline form of (S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl]propanoic acid
SI200030350T SI1237855T1 (en) 1999-12-03 2000-11-29 Crystalline form of (s)-2 ethoxy-3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl) propanoic acid
PL00357118A PL357118A1 (en) 1999-12-03 2000-11-29 Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid
EEP200200278A EE200200278A (en) 1999-12-03 2000-11-29 Crystalline form of (S) -2-ethoxy-3- [4- (2- {4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid
DK00983618T DK1237855T3 (en) 1999-12-03 2000-11-29 Crystalline form of (S) -2-ethoxy-3- [4- (2- (4-methanesulfonyloxyphenyl) ethoxy) phenyl] propanoic acid
TR2004/01333T TR200401333T4 (en) 1999-12-03 2000-11-29 Crystalline Form of (S) -2 Ethoxy -3-4- (2-4-Methanesulfonyloxyphenyl Ethoxy) Phenyl] Propanoic Acid
US10/148,821 US6531622B1 (en) 1999-12-03 2000-11-29 Crytalline form of (s)-2 ethoxy -3-[4-(2-{4- methanesulfonyloxyphenyl} ethoxy)phenyl]propanoic acid
ES00983618T ES2215769T3 (en) 1999-12-03 2000-11-29 CRYSTALLINE FORM OF ACID (S) -2-ETOXI-3- (4- (2- (4-METHANOSULPHONYLOXYPHENYL) ETOXI) PHENYL) PROPANOIC.
EP00983618A EP1237855B1 (en) 1999-12-03 2000-11-29 Crystalline form of (s)-2 ethoxy-3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid
CA002392038A CA2392038A1 (en) 1999-12-03 2000-11-29 Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid
AT00983618T ATE261431T1 (en) 1999-12-03 2000-11-29 CRYSTALLINE FORM OF (S)-2-ETHOXY-3-4-(2-4- METHANESULFONYLOXYPHENYL-ETHOXY)PHENYL)PROPANE ACID E
MYPI20005604A MY135954A (en) 1999-12-03 2000-11-30 Crystalline form of (s)-ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid
CO00091767A CO5271735A1 (en) 1999-12-03 2000-11-30 CRYSTAL FORM
ARP000106382A AR029412A1 (en) 1999-12-03 2000-12-01 CRYSTAL FORM
IS6400A IS6400A (en) 1999-12-03 2002-05-28 Crystalline form (S) -2-ethoxy-3- [4- (2- {4-methanesulfonylphenyl} ethoxy) phenyl] propanoic acid
NO20022598A NO20022598D0 (en) 1999-12-03 2002-05-31 Crystalline form of (S) -2-ethoxy-3- [4-methanesulfonyloxyphenyl} -ethoxy) -phenyl] -propanoic acid
HK03101132A HK1048980A1 (en) 1999-12-03 2003-02-17 Crystalline form of (s)-2 ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) phenylÜ propanoic acid (s)-2-3-Ä4

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0001187A SE0001187D0 (en) 2000-04-03 2000-04-03 Crystalline form

Publications (1)

Publication Number Publication Date
SE0001187D0 true SE0001187D0 (en) 2000-04-03

Family

ID=20279126

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0001187A SE0001187D0 (en) 1999-12-03 2000-04-03 Crystalline form

Country Status (1)

Country Link
SE (1) SE0001187D0 (en)

Similar Documents

Publication Publication Date Title
DK1226127T3 (en) Substituted phenylsulfamoylcarboxamides
NO20026196L (en) Kinazolinditosylatsalt compounds
ATE307121T1 (en) SUBSTITUTED ARYLPYRAZINE
DK1619192T3 (en) Aryl-condensed azapolycyclic compounds
AR028393A1 (en) SUBSTITUTED IMINOAZIDS
ATA2932001A (en) SNOWTHROWER
EE05197B1 (en) Linezolid - Crystalline Form II
AR028336A1 (en) 4-HYDROXI-TETRAHYDROPIRIDONAS PHENYLSUBSTITUIDAS
AR028302A1 (en) SUBSTITUTED FENILURACILOS
DE50112662D1 (en) SUBSTITUTED BENZOYLCYCLOHEXENONE
ID29755A (en) COMPOUND ORGANOSYLICONE
ATE372338T1 (en) DESHALOGEN COMPOUNDS
AR028061A1 (en) 2-ENAMINO-CETONITRILOS FENIL-SUBSTITUIDOS
AR027931A1 (en) ANTITRANSPIRANTS
NO20023508D0 (en) Calcilitic compounds
NO20030303D0 (en) Calcilitic compounds
NO20031837D0 (en) Calcilitic compounds
TR200100070A3 (en) Compound
AR027982A1 (en) ARIL- AND HETEROARILSULFONATOS
NO20024679L (en) Crystalline Pharmaceuticals
AT500246B8 (en) CHOKERRING
FR2817889B1 (en) FORM
SE0001422D0 (en) Crystalline form
SE0001187D0 (en) Crystalline form
ATA17542000A (en) HYDRAULIKZYLINDER